Early Episode Psychosis
Early-episode psychosis is a prime time for medical intervention, which may include multimodal therapies, case management, and a focus on self-determination. Treatment focuses on enabling individuals to move on from the acute impact of a psychotic episode and chart the course of their own recovery. In this Early Episode Psychosis Topic Library, find resources about treatment interventions and other information.
Featured Resources
Northwestern University Recovery From Early Episode Psychosis Program (REPP)
-
The EARLY Clinic Program: Treating First-Episode Psychosis
VideoAugust 10, 2020This informative recording features Mauricio Tohen, MD, DrPH, MBA, Chairman of the Department of Psychiatry and Behavioral Sciences at the… -
Interview With A Patient In A First-Episode Psychosis (FEP) Program
InterviewSeptember 7, 2020Join Elizabeth DiNapoli, PhD, Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc., as she interviews Kyran Phillips, an individual… -
Does Stigma In First-Episode Psychosis Impact Outcomes?
ArticleMay 4, 2020Awareness and exploration of the scope and consequences of stigma toward mental illness in general—and psychotic disorders in particular—is a…
63% Of People With Schizophrenia Take Medications Raising Risk Of Cognitive Impairment
-
Homeless Consumers With Chronic Mental Illness Have 32% Higher Health Costs Than Those Supportive Housing
ArticleJune 28, 2021 -
Shared Decision-Making & Supporting Changes In Treatment
VideoJune 24, 2021 -
What Role Can LAIs Play In Early-Phase Schizophrenia?
VideoJune 23, 2021
Early Episode Psychosis Resources
Ask A Question About Early Episode Psychosis
Enter your question in the box below and click “Ask My Question” to submit your inquiry.
You must be logged in to ask a question in this section.
Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.
REQUEST A PRESENTATION
Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.
Top Requested Presentations
The Neuropsychiatric Inventory: Development & Applications
Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR
Distinguishing Sedation From Efficacy In Antipsychotic Treatment
Learning Tracks
Not sure where to start on the thousands of resources in the PsychU library? PsychU has created learning tracks to give community members a resource guide! Pick a learning track, review the materials outlined, and complete the Test Your Knowledge questions to participate in a resource ‘crash-course’ on one of the topics listed below.